Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Dexamethasone-induced lipolysis increases the adverse effect of adipocytes on osteoblasts using cells derived from human mesenchymal stem cells.

Wang D, Haile A, Jones LC.

Bone. 2013 Apr;53(2):520-30. doi: 10.1016/j.bone.2013.01.009. Epub 2013 Jan 15.

PMID:
23328495
2.

Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro.

Elbaz A, Wu X, Rivas D, Gimble JM, Duque G.

J Cell Mol Med. 2010 Apr;14(4):982-91. doi: 10.1111/j.1582-4934.2009.00751.x. Epub 2009 Mar 27.

4.

Implication of fatty acids in the inhibitory effect of human adipocytes on osteoblastic differentiation.

Lucas S, Clabaut A, Ghali O, Haren N, Hardouin P, Broux O.

Bone. 2013 Aug;55(2):429-30. doi: 10.1016/j.bone.2013.04.010. Epub 2013 Apr 23. No abstract available.

PMID:
23619466
5.

Response to "Implication of fatty acids in the inhibitory effect of human adipocytes on osteoblastic differentiation".

Wang D, Haile A, Jones LC.

Bone. 2013 Aug;55(2):431. doi: 10.1016/j.bone.2013.04.009. Epub 2013 Apr 20. No abstract available.

PMID:
23612488
6.

The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.

Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM.

Osteoporos Int. 2013 May;24(5):1647-61. doi: 10.1007/s00198-012-2138-z. Epub 2012 Oct 27.

PMID:
23104199
7.

Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.

Ghali O, Broux O, Falgayrac G, Haren N, van Leeuwen JP, Penel G, Hardouin P, Chauveau C.

BMC Cell Biol. 2015 Mar 13;16:9. doi: 10.1186/s12860-015-0056-6.

8.

FFAs-ROS-ERK/P38 pathway plays a key role in adipocyte lipotoxicity on osteoblasts in co-culture.

Dong X, Bi L, He S, Meng G, Wei B, Jia S, Liu J.

Biochimie. 2014 Jun;101:123-31. doi: 10.1016/j.biochi.2014.01.002. Epub 2014 Jan 11.

PMID:
24424405
9.

Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.

Clabaut A, Delplace S, Chauveau C, Hardouin P, Broux O.

Differentiation. 2010 Jul;80(1):40-5. doi: 10.1016/j.diff.2010.04.004. Epub 2010 May 12.

PMID:
20466479
10.

Adipocytes derived from human bone marrow mesenchymal stem cells exert inhibitory effects on osteoblastogenesis.

Zhang H, Lu W, Zhao Y, Rong P, Cao R, Gu W, Xiao J, Miao D, Lappe J, Recker R, Xiao GG.

Curr Mol Med. 2011 Aug;11(6):489-502.

PMID:
21663588
11.
12.

Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.

Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I.

Dev Biol. 1994 Jan;161(1):218-28.

PMID:
8293874
13.

Osteogenic differentiation is synergistically influenced by osteoinductive treatment and direct cell-cell contact between murine osteoblasts and mesenchymal stem cells.

Tsai MT, Lin DJ, Huang S, Lin HT, Chang WH.

Int Orthop. 2012 Jan;36(1):199-205. doi: 10.1007/s00264-011-1259-x. Epub 2011 May 13.

14.
15.
16.

Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells.

Alm JJ, Heino TJ, Hentunen TA, Väänänen HK, Aro HT.

Tissue Eng Part C Methods. 2012 Sep;18(9):658-66. doi: 10.1089/ten.TEC.2011.0675. Epub 2012 May 14.

PMID:
22428545
17.

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Bäckesjö CM, Li Y, Lindgren U, Haldosén LA.

J Bone Miner Res. 2006 Jul;21(7):993-1002.

18.

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F.

BMC Cancer. 2010 Jun 17;10:298. doi: 10.1186/1471-2407-10-298.

19.
20.

Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders.

Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M.

J Bone Miner Res. 1998 Mar;13(3):371-82.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk